EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study

Ahmed Kadom Kalaf, Khawla A. Shemran, Waleed Azeez AlAmeedy

International Journal of Nutrology · 30.07.2026 · 19 (S3)

DOI: 10.54448/ijn26s315 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Nutrology, online erschienen am 30.07.2026. Verfasst von Ahmed Kadom Kalaf und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer's disease (AD) is a chronic neurodegenerative illness characterised by aberrant protein accumulation and progressive cognitive decline. One of the most researched blood indicators of tau pathology is phosphorylated tau 217 (p-tau217), and apolipoprotein E (ApoE) is essential for lipid metabolism, amyloid removal, and neuronal maintenance. The severity of AD may be correlated with changes in these biomarkers.

Objective

To compare serum levels of p-tau217 and ApoE in individuals with different severities of Alzheimer's Disease.

Methods

The present case–control study consisted of 156 subjects aged between 55 and 85 years:106 patients with ad (and balanced frequency matched to healthy controls on age, international classification of diseases t63 diagnosis). The DSM-5 criteria classified the patients as mild (n = 12), moderate (n = 50), or severe (n = 44). Using the sandwich enzyme-linked immunosorbent assay (ELISA), the levels of circulating ApoE and p-tau217 were determined. The receiver operating characteristics (ROC) curve examination, Spearman's correlation, and the Kruskal-Wallis test were used in the statistical studies.

Results

The mean serum p-tau217 and ApoE level were 165 ± 84.2 pg/mL and 75.5 ± 55.6 ng/mL, respectively. While serum p-tau217 significantly increased with severity of disease, ApoE levels decreased. We found a significant positive association of p-tau217 (p

Zitieren

APA

Kalaf, A. K., Shemran, K. A., & AlAmeedy, W. A. (2026). Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study. International Journal of Nutrology, 19(S3). https://doi.org/10.54448/ijn26s315

Vancouver

Kalaf AK, Shemran KA, AlAmeedy WA. Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study. International Journal of Nutrology. 2026;19(S3). doi:10.54448/ijn26s315

BibTeX
@article{Kalaf2026,
  author = {Kalaf, Ahmed Kadom and Shemran, Khawla A. and AlAmeedy, Waleed Azeez},
  title = {Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study},
  journal = {International Journal of Nutrology},
  year = {2026},
  volume = {19},
  number = {S3},
  doi = {10.54448/ijn26s315}
}
Kostenlos starten →